Gonal-F Gonal-F View 1

Gonal-F

Gonal-f (Follitropin alfa, r-FSH) is another recombinant (synthetic) version of human follicle stimulating hormone, almost identical to that contained in Follistim. Available data tell us the differences between the two versions of the hormone are indistinguishable. It is indicated for women undergoing Ovulation Induction Treatment and also for women participating in an Assisted Reproductive Technology (ART) program, such as in vitro fertilization.

Available as

Size Price Qty Add
1050 U - 1 Kit
RRP: $2,002.00
You pay: $1,599.95 (Save 20%)
450 U - 1 Kit
RRP: $858.00
You pay: $699.95 (Save 18%)

General Product Information About Gonal

Gonal Product Contains

Follitropin alfa, r-FSH

Product Indications

Gonal-f (Follitropin alfa, r-FSH) is another recombinant (synthetic) version of human follicle stimulating hormone, almost identical to that contained in Follistim. Available data tell us the differences between the two versions of the hormone are indistinguishable. It is indicated for women undergoing Ovulation Induction Treatment and also for women participating in an Assisted Reproductive Technology (ART) program, such as in vitro fertilization.

Gonal Dosage and Administration

NOTE: During FSH treatment and for 2 weeks after treatment, patients need to be checked every day (or every other day) for signs of too much ovarian stimulation.

Induction of ovulation and pregnancy in patients who do not ovulate when infertility is not due to ovarian failure

    Initial dose 75 IU subcutaneously once daily. Dose may be increased by 37.5 IU/day. Maximum dose 300 IU/day. Response is evident within 5-7 days. Duration of treatment should not exceed 35 days. hCG should be given 1 day after the last dose unless the serum estradiol is greater than 2000 pg/mL.

For the development for multiple follicles in patient¿s participating in assisted reproductive programs

    Initial dose 150 IU subcutaneously in the early follicular phase (days 2 or 3) and continue 150 IU once daily until follicle development is adequate Administer hCG should be administered to retrieve oocyte. Retrieval should occur 34-36 hours later Do not exceed 10 days of therapy If needed initial dose can be 225 IU/day and may be increased by 75-150 IU/day (every 3-5 days). Maximum dose 450 IU/day.

Gonal Warnings, Side Effects and Potential Drug Interactions

  • Discontinue treatment if the ovaries become abnormally enlarged or if abdominal pain occurs and contact your physician
  • Do not use if pregnant or breastfeeding
  • Sexual intercourse is prohibited if ovaries are enlarged
  • Product can exacerbate asthma and other pulmonary conditions
  • May enhance some cancers such as ovarian or breast cancer

Gonal Storage

  • Store in refrigerator or at room temperature, between 36°-77° F (2°-25° C).
  • Once reconstituted, discard after 28 days.
  • Avoid excessive heat, humidity, and light.
  • Do not shake.

Gonal Manufacturer

Emd Serono, Inc
Telephone: 1-888-275-7376
Website: www.emdserono.com

Approved by the FDA
Federal law restricts/prohibits dispensing without prescription.

Style Number: EMD-RFO-00001-CONFIG